Workflow
CVS Health - Q2 Earnings Are A Referendum On Future Of Company

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?At the time of writing, CVS Health (NYSE: CVS ) stock trades at $64 per share, which is more or less the same price it tradedThe group is for both novice and experienced biotech investors. It provides catalysts to ...